1. 01
   The pharmacy is named and licensedA real 503A pharmacy or 503B outsourcing facility with a license number you can look up on the state board of pharmacy. "Our network of partner pharmacies" with no name is a red flag. (NexLife, for example, names partners such as Absolute, Hallandale, Red Rock, Empower, and Strive.)
2. 02
   A named US physician prescribes after a real evaluationA real clinician name and state license, after an actual intake — not an anonymous form rubber-stamp.
3. 03
   LegitScript or NABP certificationNot legally required, but it signals third-party-audited compliance and is what payment processors and ad platforms use to screen telehealth merchants.
4. 04
   No "research use only" disclaimerThat phrase means the product is not intended for human use and is being sold outside the law. Walk away immediately.
5. 05
   Third-party batch testingIndependent lab testing for potency, sterility, pH, and endotoxin. Sterility failures in injectables are the FDA's core safety concern.
6. 06
   Published, dose-independent pricingThe price should be visible before intake and ideally flat across the titration — not a teaser that balloons at maintenance dose.
7. 07
   Clear refund, cancellation, and data termsKnow the cancellation policy, whether auto-renew is on by default, and how your health data is handled.

Because broad compounding is now restricted (see our 2026 legal status explainer), also confirm the provider is operating under a compliant patient-specific 503A model or routing to an FDA-registered 503B facility. If anything is unclear, ask directly — a legitimate provider answers these questions plainly.

This is a sensitive area for health and safety. This checklist is educational and not medical or legal advice; consult a licensed clinician and your state board of pharmacy.